Becker's Hospital Review | Healthcare News & Analysis

Author's posts

Amgen builds $474M facility in Ohio

Amgen, a biotech company, has built a $474 million facility in New Albany, Ohio, NBC affiliate WCMH reported Feb. 26.

South Dakota floats video to clarify abortion ban for clinicians 

South Dakota lawmakers are proposing a bill that would require the creation of an educational video to clarify when abortion is legal in the state, KFF Health News reported Feb. 27.

AHA says Change Healthcare attack will impact hospital finances

The American Hospital Association penned a letter to the HHS about the Change Healthcare attack stating that the incident will have “an immediate adverse impact on hospitals’ finances.”

HCA Florida hospital addresses equipment sterilization issues

HCA Florida North Florida Hospital in Gainesville, which shut down procedures earlier this year to address equipment sterilization issues, has resumed all surgical operations.

Inspired by a legendary surgeon, Cleveland Clinic heart chief advances 'maturing' technologies

Lars Svensson, MD, PhD, was on vacation in 1967 when he and his father heard about the first person-to-person heart transplant, performed by South African surgeon Christiaan Barnard. 

Biden administration responds to Alabama's IVF ruling

White House Press Secretary Karine Jean-Pierre called the Alabama Supreme Court’s recent ruling that frozen embryos are considered children “shameful” during a Feb. 26 press briefing. It was the first time the White House responded to the decision that…

R1 RCM posts $3.3M in 2023 income

R1 RCM reported a $3.3 million net income in 2023 after posting a net loss of $63.3 million in 2022, according to its Feb. 27 financial statement.  

A weight loss drug candidate could rival Ozempic

Viking Therapeutics reported Feb. 27 strong results from a phase 2 trial of a new drug that could rival other GLP-1 anti-obesity medications like Ozempic, Mounjaro and Wegovy.

A weight loss drug candidate could rival Ozempic

Viking Therapeutics reported Feb. 27 strong results from a phase 2 trial of a new drug that could rival other GLP-1 medications like Ozempic, Mounjaro and Wegovy.

Cyber framework cuts healthcare insurance premium hikes

Healthcare organizations utilizing the National Institute of Standards and Technology Cybersecurity Framework as their primary framework experienced smaller increases in cyber insurance premiums than those not employing the NIST CSF, a Feb. 27 report f…